SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001193805-24-000829
Filing Date
2024-06-18
Accepted
2024-06-18 21:01:30
Documents
1
Period of Report
2024-06-14

Document Format Files

Seq Description Document Type Size
1 e663730_4-jing.html 4  
1 e663730_4-jing.xml 4 8369
  Complete submission text file 0001193805-24-000829.txt   9855
Mailing Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121 8589002660
Arcturus Therapeutics Holdings Inc. (Issuer) CIK: 0001768224 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O KRYSTAL BIOTECH, INC. 2100 WHARTON STREET, SUITE 701 PITTSBURGH PA 15203
Business Address
Marantz Jing L. (Reporting) CIK: 0001834528 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38942 | Film No.: 241053780